EUVIMEDEUVIMED entdecken
Crossref

Prediction of tumour-infiltrating lymphocytes in triple-negative and HER2-positive breast cancer using multi-modality ultrasound and MRI: a single-institution retrospective study

Manqi Zhang iD, Li Gong, Mengjun Cai, Danyan Li, Jiong Shi, Yu Du iD, Pengli Yu

British Journal of Radiology · 2025

DOI: 10.1093/bjr/tqaf146 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Radiology, 2025. Verfasst von Manqi Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Triple Negative Breast Neoplasms, Lymphocytes, Tumor-Infiltrating, Multimodal Imaging. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To explore the potential of non-invasive imaging techniques in predicting tumour-infiltrating lymphocytes (TILs) status in triple-negative (TN) and HER-2 positive breast cancers.

Methods

Between April 2018 and November 2023, a total of 432 eligible TN and HER-2 positive breast cancers who underwent ultrasound (US) and magnetic resonance imaging (MRI) were retrospectively enrolled in this study. US and MRI variables were collected from the workstation. Fraction of TILs was determined histologically based on the proportion of lymphocytes infiltrated areas. A cutoff of 20% was established to distinguish between low and high levels of TILs. Predictive factors associated with high-TILs were identified using logistic regression analysis and a nomogram was developed. The diagnostic performance of the nomogram was evaluated.

Results

A total of 432 patients with TN and HER2-positive breast cancer were evaluated, among which 228 patients (52.7%) exhibited high levels of TILs. Oval/round shape (odds ratio, [OR], 0.148; P = .001), circumscribed margin (OR, 0.174; P = .001), heterogeneous echotexture (OR, 7.106; P = .001), mass-like lesion type on DCE-MRI (OR, 0.425; P = .022), and homogeneous internal enhancement (OR, 0.144; P = .001) were all significantly linked to high-TILs. The nomogram based on these characteristics yielded an optimal area under the curve (AUC) of 0.884 (95% confidence interval [CI], 0.846–0.921) in the training set and 0.883 (95% CI, 0.825–0.940) in the test set. The calibration curve showed favourable calibration ability.

Conclusion

The nomogram includes imaging features from both US and MRI, which are crucial for predicting high levels of TILs in TN and HER2-positive breast cancers. Advances in knowledge Pretreatment US and MRI features have the potential to non-invasively predict TILs’ levels in TN and HER2-positive breast cancer. These findings may aid in treatment decision-making and improve prognostic assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingTriple Negative Breast NeoplasmsLymphocytes, Tumor-InfiltratingMultimodal ImagingUltrasonography, MammaryBreast NeoplasmsHumansFemaleRetrospective StudiesMiddle AgedErb-b2 Receptor Tyrosine KinasesAdultAgedNomogramsUltrasonography

Stichwörter der Autor:innen

magnetic resonance imagingtumour-infiltrating lymphocytesultrasound

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Department of Ultrasound, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.
  • Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.
  • Department of Pathology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China.
  • Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.

ORCID-Profile: Manqi Zhang, Yu Du

Zitieren

APA

Zhang, M., Gong, L., Cai, M., Li, D., Shi, J., Du, Y., & Yu, P. (2025). Prediction of tumour-infiltrating lymphocytes in triple-negative and HER2-positive breast cancer using multi-modality ultrasound and MRI: a single-institution retrospective study. British Journal of Radiology. https://doi.org/10.1093/bjr/tqaf146

Vancouver

Zhang M, Gong L, Cai M, Li D, Shi J, Du Y, et al. Prediction of tumour-infiltrating lymphocytes in triple-negative and HER2-positive breast cancer using multi-modality ultrasound and MRI: a single-institution retrospective study. British Journal of Radiology. 2025. doi:10.1093/bjr/tqaf146

BibTeX
@article{Zhang2025,
  author = {Zhang, Manqi and Gong, Li and Cai, Mengjun and Li, Danyan and Shi, Jiong and Du, Yu and Yu, Pengli},
  title = {Prediction of tumour-infiltrating lymphocytes in triple-negative and HER2-positive breast cancer using multi-modality ultrasound and MRI: a single-institution retrospective study},
  journal = {British Journal of Radiology},
  year = {2025},
  doi = {10.1093/bjr/tqaf146}
}
Kostenlos starten →